www.nytimes.com
1 month agoOMG science
F.D.A. Approves Drug for Persistently Deadly Form of Lung Cancer
The FDA approved a new treatment, tarlatamab, for small cell lung cancer patients with limited life expectancy, showing potential with tripled life expectancy and practice-changing impact. [ more ]